Ameriprise
AGN

Ameriprise’s Allergan plc AGN Stock Holding History

Ameriprise’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-698,128
Closed -$124M – 3788
2020
Q1 		$124M Sell
698,128
-700,076
-50% -$132M 0.06% 286
2019
Q4 		$267M Sell
1,398,204
-513,354
-27% -$92.6M 0.11% 193
2019
Q3 		$322M Sell
1,911,558
-1,367,248
-42% -$223M 0.14% 152
2019
Q2 		$549M Buy
3,278,806
+614,316
+23% +$85.1M 0.25% 82
2019
Q1 		$390M Sell
2,664,490
-286,769
-10% -$41.6M 0.18% 113
2018
Q4 		$394M Buy
2,951,259
+387,526
+15% +$63.5M 0.2% 100
2018
Q3 		$1.16B Buy
2,563,733
+411,640
+19% +$75.6M 0.41% 44
2018
Q2 		$359M Sell
2,152,093
-2,009
-0.1% -$323K 0.16% 134
2018
Q1 		$363M Sell
2,154,102
-98,666
-4% -$16.5M 0.16% 140
2017
Q4 		$369M Buy
2,252,768
+499,798
+29% +$89.7M 0.17% 134
2017
Q3 		$359M Sell
1,752,970
-24,724
-1% -$5.75M 0.17% 127
2017
Q2 		$432M Buy
1,777,694
+156,898
+10% +$36.9M 0.22% 105
2017
Q1 		$388M Buy
1,620,796
+469,462
+41% +$109M 0.2% 110
2016
Q4 		$242M Buy
1,151,334
+289,061
+34% +$59.9M 0.13% 160
2016
Q3 		$199M Sell
862,273
-216,672
-20% -$52.9M 0.11% 190
2016
Q2 		$249M Sell
1,078,945
-280,169
-21% -$64.6M 0.15% 147
2016
Q1 		$364M Buy
1,359,114
+183,992
+16% +$52.7M 0.22% 105
2015
Q4 		$367M Buy
1,175,122
+81,734
+7% +$24.3M 0.22% 98
2015
Q3 		$297M Sell
1,093,388
-151,754
-12% -$46.6M 0.18% 115
2015
Q2 		$378M Sell
1,245,142
-37,516
-3% -$11.2M 0.22% 103
2015
Q1 		$382M Buy
1,282,658
+14,820
+1% +$4.23M 0.22% 102
2014
Q4 		$326M Buy
1,267,838
+546,055
+76% +$136M 0.19% 127
2014
Q3 		$174M Sell
721,783
-15,610
-2% -$3.49M 0.1% 201
2014
Q2 		$164M Buy
737,393
+73,371
+11% +$15.2M 0.1% 216
2014
Q1 		$137M Sell
664,022
-122,886
-16% -$24.3M 0.08% 247
2013
Q4 		$132M Sell
786,908
-440,624
-36% -$68.9M 0.08% 259
2013
Q3 		$177M Sell
1,227,532
-260,246
-17% -$34.7M 0.12% 195
2013
Q2 		$188M Buy
+1,487,778
New +$168M 0.13% 189

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ameriprise's AGN Position: Q2 2020 in Review

Ameriprise sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 698,128 shares — an estimated $124M sold.

Ameriprise first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.16B in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ameriprise reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ameriprise sold 698,128 Allergan plc shares in Q2 2020, an estimated $124M.
  • Ameriprise first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Ameriprise's Allergan plc position peaked at $1.16B in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ameriprise's 13F filing for Q2 2020, filed 14 Aug 2020.